PCA
CELG.RT

Purkiss Capital Advisors’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History

Purkiss Capital Advisors’s Portfolio CELG.RT Stock Details CELG.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$661 Hold
26,450
– – ﹤0.01% 153
2025
Q1 		$1.32K Hold
26,450
– – ﹤0.01% 109
2024
Q4 		$1.3K Buy
+26,450
New +$1.3K ﹤0.01% 100